5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
Magnetic resonance imaging (MRI) scans are increasingly first-line investigations for suspected prostate cancer, and essential in the decision for biopsy. 5-alpha reductase inhibitor (5-ARI) use has been shown...
Source: BMC Urology - Category: Urology & Nephrology Authors: Ziting Wang, Kaiying Wang, Han Yang Ong, Woon Chau Tsang, Qing Hui Wu and Edmund Chiong Tags: Research article Source Type: research
More News: Cancer | Cancer & Oncology | MRI Scan | PET Scan | Prostate Cancer | Urology & Nephrology